On February 1, 2021 Corcept Therapeutics Incorporated (NASDAQ: CORT) reported it will report its preliminary 2020 fourth quarter and full-year financial results and provide a corporate update on February 8, 2021 (Press release, Corcept Therapeutics, FEB 1, 2021, https://ir.corcept.com/news-releases/news-release-details/corcept-therapeutics-announce-preliminary-selected-financial [SID1234574452]). The company will host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information

To participate, dial 1-833-693-0540 (United States) or 1-661-407-1581 (internationally) approximately 15 minutes before the start of the call. The conference ID number is 9289307.

For access to the call in "listen-only" mode, click this link and provide the requested information. The link will be active 15 minutes prior to the call’s scheduled start time.